9CQA image
Entry Detail
PDB ID:
9CQA
Title:
Structure of antibody 1G1 bound to the central conserved region of RSV G
Biological Source:
PDB Version:
Deposition Date:
2024-07-19
Release Date:
2025-02-19
Method Details:
Experimental Method:
Resolution:
1.74 Å
R-Value Free:
0.22
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Mature secreted glycoprotein G
Chain IDs:E (auth: A), F (auth: B)
Chain Length:49
Number of Molecules:2
Biological Source:Respiratory syncytial virus A2
Polymer Type:polypeptide(L)
Description:Fab 1G1 Heavy Chain
Chain IDs:A (auth: E), C (auth: D)
Chain Length:264
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Fab1G1 Light Chain
Chain IDs:B (auth: F), D (auth: G)
Chain Length:215
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structures of respiratory syncytial virus G bound to broadly reactive antibodies provide insights into vaccine design.
Sci Rep 15 8666 8666 (2025)
PMID: 40082629 DOI: 10.1038/s41598-025-92886-w

Abstact

Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract disease in infants and older adults. The attachment glycoprotein (RSV G) binds to the chemokine receptor CX3CR1 to promote viral entry and modulate host immunity. Antibodies against RSV G are a known correlate of protection. Previously, several broadly reactive, high-affinity anti-RSV G human monoclonal antibodies were isolated from RSV-exposed individuals and were shown to be protective in vitro and in vivo. Here, we determined the structures of three of these antibodies in complex with RSV G and defined distinct conformational epitopes comprised of highly conserved RSV G residues. Binding competition and structural studies demonstrated that this highly conserved region displays two non-overlapping antigenic sites. Analyses of anti-RSV G antibody sequences reveal that antigenic site flexibility may promote the elicitation of diverse antibody germlines. Together, these findings provide a foundation for next-generation RSV prophylactics, and they expand concepts in vaccine design for the elicitation of germline lineage-diverse, broadly reactive, high-affinity antibodies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures